Michael T Corbett

Title: Michael T Corbett: Innovator in Cancer Treatment

Introduction

Michael T Corbett is a prominent inventor based in San Carlos, CA (US). He has made significant contributions to the field of cancer treatment through his innovative research and development of new compounds. With a total of 3 patents, Corbett's work focuses on synthesizing inhibitors for KRAS G12C mutated cancers.

Latest Patents

Corbett's latest patents include the "Synthesis of KRAS G12C inhibitor compound," which describes an improved, efficient, and scalable process to prepare intermediate compounds. These compounds are essential for developing treatments for KRAS G12C mutated cancers. Another notable patent is the "Process for preparing 7-chloro-6-fluoro-1-(2-isopropyl-4-methylpyridin-3-yl)pyrido[2,3-d]pyrimidine-2,4(1H,3H)-dione." This patent outlines a detailed process for synthesizing compound A, which is crucial for the synthesis of AMG 510.

Career Highlights

Corbett is currently employed at Amgen Inc., a leading biotechnology company. His work at Amgen has allowed him to focus on developing innovative solutions for cancer treatment. His expertise in synthetic processes has positioned him as a key player in the field.

Collaborations

Throughout his career, Corbett has collaborated with notable colleagues, including Sebastien Caille and Austin G Smith. These collaborations have further enhanced his research and development efforts in the biotechnology sector.

Conclusion

Michael T Corbett is a dedicated inventor whose work in cancer treatment has the potential to make a significant impact on patient care. His innovative patents and collaborations reflect his commitment to advancing medical science.